Akeso

Pharma

Pfizer, Akeso, Lilly and more—Fierce Pharma Asia

Pfizer shared trial plans for its PD-1xVEGF drug as Akeso detailed the first OS win for its rival. Eli Lilly continued its dealmaking spree. And more.

Angus Liu Nov 14, 2025 8:50am

Fierce Biotech

Pfizer lays out its PD-1xVEGF bispecific research strategy

Nov 11, 2025 11:43am

Close up shot of the target from a dart game

Akeso details ivonescimab's 1st overall survival win

Nov 7, 2025 11:30am

Akeso, Summit's ivonescimab ups PD-1 in chemo combo in 1L NSCLC

Oct 19, 2025 10:45am

Summit's global PD-1xVEGF data show new promising OS trend

Sep 7, 2025 3:30am

Ivonescimab, Fosun-Sitala, Hutchmed—Fierce Pharma Asia

Aug 29, 2025 8:15am